As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.
For the last 10 years, Johnson & Johnson Innovation has been on a mission to accelerate early-stage innovation aimed at advancing healthcare. As digital technology external innovation lead, Varun Ramdevan looks for the best ideas—and helps make them a reality.
The key to slowing cognitive decline is diagnosing the disease as early as possible. And that's exactly what Johnson & Johnson scientists are relentlessly pursuing.
The goal of precision medicine is to develop individualized treatments based on a patient's genetic profile. Here's how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.